Latest news
FDA Approves Twice-Rejected Oncolytic Virus Combination for Melanoma - Oncology News CentralOncology News Central · Fri, 07 Aug 2026 10:27:13 GMTWhy Oncolytic Virus Therapy Is Transforming Cancer Treatment Through Precision Immunotherapy, Tumor Selectivity, and Advanced Viral Engineering: Industry Analysis and Forecast - Spherical InsightsSpherical Insights · Wed, 29 Jul 2026 12:51:12 GMT